Medical Cannabis for Intractable Epilepsy in Childhood: A Review
- PMID: 32017679
- PMCID: PMC7000162
- DOI: 10.5041/RMMJ.10387
Medical Cannabis for Intractable Epilepsy in Childhood: A Review
Abstract
In recent years, cannabis has been gaining increasing interest in both the medical research and clinical fields, with regard to its therapeutic effects in various disorders. One of the major fields of interest is its role as an anticonvulsant for refractory epilepsy, especially in the pediatric population. This paper presents and discusses the current accumulated knowledge regarding artisanal cannabis and Epidiolex®, a United States Food and Drug Administration (FDA)-approved pure cannabidiol (CBD), in epilepsy management in pediatrics, by reviewing the literature and raising debate regarding further research directions.
Conflict of interest statement
References
-
- Gowers W. Epilepsy and Other Chronic Convulsive Disorders. London: Churchill; 1881.
-
- Consroe P, Wolkin A. Cannabidiol–antiepileptic drug comparisons and interactions in experimentally induced seizures in rats. J Pharmacol Exp Ther. 1977;201:26–32. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
